Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Financial Analysis and Multi-Year Benchmarking: Puma Biotechnology Inc (PBYI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forPuma Biotechnology Inc (PBYI:NAS) compared to its top competitors and compared to ... Read More
-
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2025-2031
... expected to grow at a CAGR of 9.0% from 2025 to 2031. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth ... Read More
-
Financial Analysis and Multi-Year Benchmarking: DermTech Inc (DMTK:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forDermTech Inc (DMTK:NAS) compared to its top competitors and compared to the average for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Fortress Biotech (FBIO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forFortress Biotech (FBIO:NAS) compared to its top competitors and compared to the average for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Elanco Animal Health Incorporated (ELAN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forElanco Animal Health Incorporated (ELAN:NYS) compared to its top competitors ... Read More
-
Financial Analysis and Multi-Year Benchmarking: International Stem Cell Corp (ISCO:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forInternational Stem Cell Corp (ISCO:PINX) compared to its top competitors ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2025
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Global Research Antibodies Competitive Landscape Professional Research Report 2025
... target molecules. These antibodies are crucial tools in various fields, including molecular biology, biochemistry, immunology, and medical research. Researchers employ them for tasks such as detecting proteins, studying cellular structures, and investigating the functions of ... Read More
-
Biotechnology Market in US 2025-2029
... market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Gilead Sciences Inc (GILD:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forGilead Sciences Inc (GILD:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Bionano Genomics Inc (BNGO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forBionano Genomics Inc (BNGO:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forXOMA Corporation (XOMA:NAS) compared to its top competitors and compared to the average for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Regeneron Pharmaceuticals Inc (REGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forRegeneron Pharmaceuticals Inc (REGN:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Bruker Corporation (BRKR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forBruker Corporation (BRKR:NAS) compared to its top competitors and compared to the average for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forFate Therapeutics Inc (FATE:NAS) compared to its top competitors and compared to ... Read More
-
Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029
... market is projected to surpass USD 5.93 billion in 2029 from USD 3.73 billion in 2024, with a significant CAGR of 9.7%. Increasing demand for personalized medicines, along with advancements in cell and gene therapies, ... Read More
-
Financial Analysis and Multi-Year Benchmarking: United Therapeutics Corporation (UTHR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forUnited Therapeutics Corporation (UTHR:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Geron Corporation (GERN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forGeron Corporation (GERN:NAS) compared to its top competitors and compared to the average for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Moderna Inc (MRNA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forModerna Inc (MRNA:NAS) compared to its top competitors and compared to the average for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Sangamo Therapeutics Inc (SGMO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forSangamo Therapeutics Inc (SGMO:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Myriad Genetics Inc (MYGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forMyriad Genetics Inc (MYGN:NAS) compared to its top competitors and compared to ... Read More
-
Global Liquid Biopsy Products Competitive Landscape Professional Research Report 2025
... or cells found in various bodily fluids such as blood, urine, or cerebrospinal fluid. These products enable non-invasive testing and monitoring of diseases, particularly cancer, by providing information on tumor mutations, genetic variations, and treatment ... Read More
-
Influenza Vaccines Market, Persons Vaccinated, By Segment – Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)
... 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Acorda Therapeutics Inc (ACORQ:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forAcorda Therapeutics Inc (ACORQ:PINX) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Repligen Corporation (RGEN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forRepligen Corporation (RGEN:NAS) compared to its top competitors and compared to the average for ... Read More
Research Assistance
